Caris Life Sciences, Inc. Common Stock
CAI · Medical Laboratories · $8.5B
Powering up
Not on a screen at the moment — no base, so no pivot to draw. The price and volume are below.
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
The read
Caris Life Sciences, Inc. Common Stock is not on any of the screens right now. Its relative strength rating is 85, and it sits in Medical Laboratories.
Peers
Catalyst roadmap
Nothing dated in the next three months that we can ingest automatically.
Flagged by the market sweep
Several insiders soldInsider · 2026-09-18
2 insiders sold $26,966,187
GappedTape · 2026-09-18
+9.6%
GappedTape · 2026-09-16
+9.4%
GappedTape · 2026-09-15
+7.0%
From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.
In the news
Strength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength?Zacks Investment Research · 4 days ago
Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.
Insiders
No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.
X-ray